(Received for publication, December 26, 1996, and in revised form, March 18, 1997)
From the Laboratories for Reproductive Biology, Department of Pediatrics, University of North Carolina School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599
The 20-kDa protein gene is androgen regulated in rat ventral prostate. Intron 1 contains a 130-base pair complex response element (D2) that binds androgen (AR) and glucocorticoid receptor (GR) but transactivates only with AR in transient cotransfection assays in CV1 cells using the reporter vector D2-tkCAT. To better understand the function of this androgen-responsive unit, nuclear protein interactions with D2 were analyzed by DNase I footprinting in ventral prostate nuclei of intact or castrated rats and in vitro with ventral prostate nuclear protein extracts from intact, castrated, and testosterone-treated castrated rats. Multiple androgen-dependent protected regions and hypersensitive sites were identified in the D2 region with both methods. Mobility shift assays with 32P-labeled oligonucleotides spanning D2 revealed specific interactions with ventral prostate nuclear proteins. Four of the D2-protein complexes decreased in intensity within 24 h of castration. UV cross-linking of the androgen-dependent DNA binding proteins identified protein complexes of approximately 140 and 55 kDa. The results demonstrate androgen-dependent nuclear protein-DNA interactions within the complex androgen response element D2.
Steroid hormone receptors regulate gene transcription through a
multistep process that requires binding to DNA sequences known as
hormone response elements (HREs)1 (1). HREs
consist of a 15-bp partial palindromic sequence 5-AGNACAnnnTGTNCT-3
and are found in a variety of genes regulated by a glucocorticoid
receptor (GR), progesterone receptor (PR), or androgen receptor (AR).
Studies on the androgen-regulated prostatein C3 subunit gene identified
an androgen response element (ARE) within the first intron that also
functions as a glucocorticoid response element (GRE) in transient
cotransfection assays (2, 3). ARE/GREs in the MMTV-LTR, tyrosine
aminotransferase, and prostate-specific antigen genes mediate
transcriptional responses to AR and GR (4-8). A functional ARE has
also been identified in the promoter region of the androgen-regulated
aldose reductase-like protein from mouse vas deferens (9). Since
different classes of steroid receptors co-exist in the same cell, the
commonality of shared DNA consensus sequences raises the question as to
how steroid-specific gene regulation is achieved.
ARE specificity has been described in larger complex elements such as
those 5 of the mouse sex limited protein (Slp) gene (10-15), in the
promoter region of the rat probasin gene (16, 17), and in intron 1 of
the rat 20-kDa protein gene (18). These complex elements contain one or
more simple HREs that can bind AR and GR within the context of a larger
element that binds other nuclear proteins. Androgen-specific
responsiveness of complex AREs appears to involve DNA binding proteins
that function in cooperation with AR (10-20). Functional analyses of
control regions of the genes encoding sex-limited protein (10-15),
prostate-specific antigen (8, 21), and the C3 subunit gene of
prostatein (2, 22, 23) indicate that regulatory sequences outside the
AR binding site contribute to the androgen response. Functional
cooperativity is known to occur between HREs and recognition sequences
for other transcription factors (24, 25). However, little is known
about the characteristics of proteins that interact with complex
AREs.
The 20-kDa protein gene codes for a major androgen-regulated secretory
protein in rat ventral prostate and lacrimal gland (18, 19, 26, 27).
Studies in our laboratory have shown that within the first intron of
this gene is a complex enhancer that responds selectively to AR (Fig.
1). This 358-bp sequence, referred to as fragment In-1c, binds both AR
and GR, but in CV1 cells, it confers only AR-dependent
transactivation in transient cotransfection assays (18). In PC3 and
HeLa cells, transactivation was observed with both AR and GR; however,
AR-induced activation was greater than that of GR. A 130-bp subfragment
of In-1c, referred to as D2, retained ARE specificity in all three cell
lines. D2 mediates transactivation by AR but does not contain a strong
consensus 15-bp partial palindromic response element. We have
identified a novel AR binding sequence in the 5-end of this
fragment.2
Androgen regulation of the 20-kDa protein gene requires new protein synthesis. The 20-kDa protein gene mRNA decreased to 13% of control 2d following castration and required several hours of testosterone stimulation for return to the control level. The testosterone-induced increase in 20-kDa protein mRNA was blocked by cycloheximide, suggesting that rapidly turning-over proteins are required for AR transactivation (19). Since AR interacts directly with the D2 enhancer (18), the 20-kDa protein gene would be classified as a delayed primary response gene (28). D2 contains a number of inverted and direct repeats that may serve as recognition sites for cell-specific proteins and provide secondary structure that influences D2 interactions with other transcription control proteins. Thus, characterization of rat ventral prostate nuclear proteins that bind D2 is important in understanding the function of this androgen-responsive unit in the regulation of transcription.
Here we report androgen-dependent nuclear protein interactions with the complex androgen response element D2 in the 20-kDa protein gene first intron. DNase I footprinting in isolated ventral prostate nuclei revealed protected and hypersensitive regions, consistent with androgen regulation of D2 chromatin structure. D2 binding of nuclear proteins was demonstrated by DNase I footprinting in vitro and gel mobility shift assays. UV cross-linking of D2-bound proteins identified androgen-regulated protein complexes of 140 and 55 kDa.
Sprague-Dawley rats (250-300 g) were
purchased from Charles River Laboratories (Wilmington, MA). Rats were
castrated through a scrotal incision made under anesthesia with
ketamine hydrochloride (Bristol Laboratories, Syracuse, NY) and
acepromazine maleate (Aveco Co., Inc., Fort Dodge, IA). Castrated rats
were injected with testosterone enanthate (Schein Pharmaceutical, Inc.,
Port Washington, NY) (5 mg/kg subcutaneously) immediately after
castration. Animals were sacrificed by decapitation 24 or 48 h
post-castration. Tissues were collected, stripped of connective
tissues, frozen in liquid nitrogen, and kept at 80 °C until
preparation of nuclear extracts as described below.
Nuclei were isolated according to Rigaud et al. (29) and Scarlett and Robins (12) with the following modifications. Frozen tissue (1 g) from intact and 24- or 48-h postcastration rats was pulverized under liquid nitrogen, transferred to a 50-ml tube, and allowed to thaw on ice. All buffers used to isolate ventral prostate nuclei from intact rats contained 10 nM dihydrotestosterone (Sigma). After homogenization in 15 ml TE buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA) containing 1.5 mM NaCl, 60 mM KCl, 0.2% Nonidet P-40, 5 mM MgCl2, and 5% sucrose, using 4 strokes of a Dounce homogenizer, samples were centrifuged at 500 × g for 10 min at 4 °C. Pellets were resuspended in 10 ml of TE buffer containing 1.5 mM NaCl, 60 mM KCl, and 3 mM MgCl2. Centrifugation was repeated, the pellets containing nuclei were resuspended in 2 ml of buffer (10 mM Tris-HCl, pH 7.5, 15 mM NaCl, 66 mM KCl, 1 mM MgCl2), and nucleic acid was quantitated by absorption at A260 nm. Volumes were adjusted to 10 A/ml. Nuclei were aliquoted (250 µl), and MgCl2 and CaCl2 were added to achieve 1 and 0.5 mM, respectively. Aliquots containing 0-5 units of DNase I were incubated for 10 min at 4 °C. Cleavage reactions were terminated by addition of 50 µl of stop solution (100 mM EDTA, 4 µg/ml proteinase K) and incubation for 15 s at 50 °C. After addition of 200 µl of 2.5% sodium dodecyl sulfate and incubation at 50 °C for 2 h, 50 µl of stop solution was added, and samples were kept overnight at 50 °C. DNA was extracted twice with phenol, once with phenol/chloroform, and once with chloroform. Samples were dialyzed for 48 h with 3 changes of 500 volumes of TE buffer. DNA was digested with BamHI (1 unit/µg) to decrease viscosity prior to ligation-mediated PCR. Untreated DNA (50 µg) was methylated with dimethylsulfate and cleaved with piperidine according to Hornstra and Yang (30) to serve as a G ladder for D2 sequence alignment.
The following primers were used for ligation-mediated-PCR (5 to 3
in
the 20-kDa protein gene): D1-1 (nucleotides 2852-2875), to extend
complementary to D2 sequence; D1-2 (nucleotides 2779-2801) for
amplification and D1-3 (nucleotides 2775-2800) for labeling; reading
5
to 3
on the antisense strand of the 20-kDa protein gene sequence:
D1-1, GACAACCTTCTTCAGACACACAC; D1-2: GTCGGAAGTGGAACCAAGG and
D1-3, TCAGGGTCGGAAGTGGAACCCACAG. DNA (2 µg) was denatured 5 min at
95 °C, and primer D1-1 (1 µM) was annealed for 30 min at 61 °C, followed by extension for 10 min at 76 °C using Deep Vent polymerase (New England BioLabs, Beverly, MA). After PCR, an
overnight ligation was performed at 16 °C using linker primer (20 µM) and T4 DNA ligase (Boehringer Mannheim). DNA was
precipitated, and PCR using a ligation primer and D1-2 was performed
as follows: 1) denaturation at 95 °C for 4 min, annealing at
65 °C for 3 min, and extension at 76 °C for 2 min; 2) 18 cycles
of denaturation at 95 °C for 1 min, annealing at 65 °C for 2 min
and extension at 76 °C for 3 min adding 5 s to each subsequent
cycle; 3) extension for 10 min at 76 °C. DNA was labeled in PCR
reactions using 2.5 pmol [
32P] ATP-kinased primer
D1-3 purified from free nucleotides on Bio-Spin 30 columns (Bio-Rad).
Two rounds of PCR (4 min at 95 °C, 2 min at 66 °C, and 10 min at
76 °C) were performed, and reactions were stopped by addition of
sodium acetate to 0.3 M and EDTA to 1 mM. DNA
was extracted with phenol/chloroform and precipitated with ethanol,
followed by resuspension in formamide loading buffer and
electrophoresis on 6% sequencing gels.
1 g of frozen ventral prostate was pulverized under liquid nitrogen, placed in 10 ml of homogenization buffer (50 mM Tris-HCl, pH 7.5, 0.25 M sucrose, 10% glycerol, 3 mM MgCl2, 0.1 mM EDTA, 5 mM dithiothreitol (DTT), 0.5 µM Pefabloc®-SC (Boehringer Mannheim), 20 µg/ml pepstatin, 20 µg/ml leupeptin, and 10 µg/ml aprotinin), homogenized with 5 strokes of a Dounce homogenizer, and centrifuged at 1500 × g for 10 min at 4 °C. Pellets were resuspended in 3 volumes of extraction buffer (10 mM Tris-HCl, pH 7.5, 10% glycerol, 10 mM MgCl2, 5 mM DTT, 0.5 mM KCl, 1.1 mM EDTA, 0.5 mM Pefabloc®-SC, 20 µg/ml pepstatin, 20 µg/ml leupeptin, 10 µg/ml aprotinin), homogenized with 5 strokes in a Dounce homogenizer, and placed on ice. The suspension was frozen in dry-ice/ethanol, thawed on ice for 30 min, resuspended with a Dounce homogenizer, and centrifuged at 100,000 × g for 30 min at 4 °C. Nuclear extract pellets were resuspended in and dialyzed against DNA binding buffer (10 mM Tris-HCl, pH 7.5, 25 mM KCl, 0.1 mM EDTA, 10% glycerol, 1 mM DTT, 1 mM phenylmethylsulfonyl fluoride) for 4 h at 4 °C.
DNase I Footprinting of D2 in VitroD2 was obtained by
digestion of the reporter vector D2-ptkCAT (18) with XBaI
and 3-end-labeled using [
-32P]dCTP (3,000 Ci/mmol)
and the Klenow fragment of DNA polymerase I (Promega Corp., Madison,
WI). A second restriction digestion with HindIII yielded a
labeled 130-bp fragment (D2). D2 was purified by electrophoresis on a
5% polyacrylamide gel and isolated by electroelution. DNA-binding
reactions were carried out in 20-µl volumes with different amounts of
nuclear extract, 2 µg of poly(dI-dC), and 30 µg of bovine serum
albumin in DNA binding buffer. After 15 min on ice,
32P-labeled D2 (40,000 cpm) was added and then incubated
for 30 min on ice. MgCl2 and CaCl2 (2 mM) were added to the reaction mixture with DNase I (2 units), and the digestion was allowed to proceed for 3 min at room
temperature. DNase I digestion was stopped by the addition of 4 µl of
EDTA (50 mM). Samples were extracted with
phenol/chloroform, and D2 was precipitated, rinsed with 70% ethanol,
dried, and resuspended in 15 µl of formamide loading buffer. Samples
were denatured for 5 min at 95 °C and analyzed on an 8% sequencing
gel together with G and G + A chemical sequencing ladders prepared
according to Maxam and Gilbert (31). The gel was transferred to Whatman
3MM paper, dried, and autoradiographed at
80 °C using an
intensifying screen.
Nuclear
extracts were incubated with 2 µg of poly(dI-dC) and 30 µg of
bovine serum albumin for 15 min on ice in DNA binding buffer with or
without D2 oligonucleotide competitors (see below). The
32P-labeled probe (10,000 cpm) was added, and samples were
incubated for 15 min at room temperature. Protein-DNA complexes were
resolved on 6% polyacrylamide gels (acryl/bisacrylamide ratio 37.5:1)
buffered with 0.5 × TBE (10 mM Tris-HCl, 10 mM boric acid, 0.2 mM EDTA). Gels were
transferred to Whatmann 3MM paper, dried, and autoradiographed with an
intensifying screen at 80 °C.
Three oligonucleotide subfragments of
D2 were chemically synthesized using the phosphoramide method and an
Applied Biosystems Model 380B DNA synthesizer. Sense strand sequences
are as follows: oligo A,
5-CTACTAATGGTGATCATTAGGTGATAAAACCAGCCTGAAACCTTTT-3
, 20-kDa protein
gene nucleotides 2549 to 2594; oligo B,
5
-TAGAGTTACAAAGTATGACTACCTTTTATCCCAAAATCGATAGG-3
, nucleotides
2595 to 2638; and oligo C,
5
-ATCATTCAATTCATGCTGACTCTAAAGCCTTCCCTTCTTCTC-3
, nucleotides
2639 to 2681. Oligonucleotides A, B, and C were labeled using
[
-32P]ATP and T4 polynucleotide kinase, annealed to
the respective complementary oligonucleotide, purified on an 8%
polyacrylamide nondenaturing gel, and isolated by electroelution. For
competition studies, unlabeled double- and single-stranded
oligonucleotides were used as competitors. A 100-bp fragment from the
C3 gene (C3-C fragment) (2) was used in these studies as a nonspecific
competitor.
Nuclear proteins were incubated
with 32P-labeled probes, and protein-DNA complexes were
resolved on 6% polyacrylamide gels as described above. Gels were
exposed to UV light (254 nm) for 30 min, and D2-protein complexes were
visualized on overnight autoradiographic exposures. Bands were cut from
the gel and homogenized in SDS sample buffer (0.25 M
Tris-HCl, pH 6.8, 10% glycerol, 2.2% SDS, 1% -mercaptoethanol).
Proteins were resolved on 15% polyacrylamide denaturing gels. Controls
were from lanes with 32P-labeled probes either in the
absence of nuclear extracts or in the presence of nuclear extracts but
with no UV light exposure. Protein size was determined using
RainbowTM high molecular weight range markers (Bio-Rad
Laboratories).
The schematic shown in Fig.
1 demonstrates the structure of the 20-kDa protein gene.
We used DNase I footprinting of D2 in isolated nuclei of rat ventral
prostate and ligation-mediated PCR to detect
androgen-dependent changes in chromatin structure. Nuclei
were treated with DNase I, and ligation-mediated PCR was performed on
isolated DNA using primer sets for amplification of the D2 region in
intron 1 of the 20-kDa protein gene. DNase I cleavage sites in the
sense strand of D2 indicate the presence of protected regions and
hypersensitive sites in nuclei from intact rats compared with nuclei
isolated 24 (Fig. 2A) and 48 h (Fig. 2B) after castration. Diminished intensities of bands in
intact compared with castrate lanes 24 h after castration
demonstrate several protected regions. A few weakly protected sites
were more apparent at the lower concentration of DNase I. After 48 h, protected regions and several hypersensitive sites were revealed,
with changes spanning the full fragment. The schematic representation
in Fig. 2, C and D, illustrates the position of
these changes in the nucleotide sequence of D2 for each treatment. The
results indicate an androgen effect on chromatin structure in the
region of D2.
DNase I Footprinting of D2 in Vitro with Ventral Prostate Nuclear Proteins
DNA-protein interactions were analyzed by
DNase I footprinting in vitro using D2 end-labeled and
ventral prostate nuclear proteins (Fig. 3). Parallel
binding reactions were performed without protein as a control for the
nuclease digestion pattern of protein-free DNA. Fig. 3A
shows the results obtained with D2 end-labeled in the sense strand.
Protected regions (asterisks) and hypersensitive sites
(arrowheads) were formed with nuclear proteins from intact rats and castrated rats treated immediately with testosterone, as
compared with nuclear proteins from 48-h postcastrates, suggesting the
presence of androgen-dependent D2 binding proteins in
ventral prostate nuclei. A schematic representation of these
androgen-dependent protected regions and hypersensitive
sites in D2 is presented in Fig. 3B.
Footprinting in vitro with D2 end-labeled in the antisense
strand revealed stronger androgen-dependent protected
regions and hypersensitive sites than those obtained with D2
end-labeled in the sense strand (Fig. 4A).
Comparing Figs. 3B and 4B, similar footprints in
sense and antisense labeled D2 were observed in the inverted repeat 2 (GATAAA) present in the 5 and middle region of D2. Other locations of
footprints in sense and antisense strand are consistent with the
complex dyad symmetry within the D2 sequence and suggest that both
single- and double-stranded DNA binding proteins are involved in these
footprints. These data indicate that multiple proteins bind D2, and
some D2-protein interactions are androgen-dependent.
The tissue specificity of D2 footprints was examined using the same amounts of nuclear proteins from kidney of intact male rats. D2 DNase I digestion patterns were almost identical to those obtained in the absence of nuclear proteins (Fig. 3C).
Gel Mobility Shift Analysis of Nuclear Protein Binding to D2To further analyze the binding of androgen-regulated nuclear
proteins, three double-stranded 32P-labeled
oligonucleotides spanning D2 were synthesized and used in gel mobility
shift assays. Oligonucleotide A spans the 5-end (nucleotides 2549 to
2594), oligonucleotide B spans the middle region (nucleotides 2595 to
2638), and oligonucleotide C spans the 3
-end of D2 (nucleotides 2639 to 2681). The specificity of nuclear protein binding to these sequences
was tested using molar excess amounts of double-stranded A, B, C, and
random unlabeled oligonucleotides as competitors. Protein-DNA complexes
with 32P-labeled oligonucleotide A migrated at 3 different
positions (A1, A2, and A3) (Fig. 5A).
Complexes A1 and A2 were eliminated by an excess of unlabeled
double-stranded oligonucleotide A but not by oligonucleotide C or a
random oligonucleotide. When 32P-labeled oligonucleotide B
was used as a probe, four DNA-protein complexes were observed (Fig.
5B). Minor complexes (B1 and B2) and one major complex (B4)
were competed with unlabeled double-stranded oligonucleotide B but not
with oligonucleotide C or a random oligonucleotide. Bands A3 and B3
were not competed either by the specific or nonspecific unlabeled
oligonucleotides, indicating nonspecific protein binding. Competition
assays suggested that proteins involved in complexes A1 and A2 are
related to bands B1 and B2 since unlabeled oligonucleotide B competed
for complexes A1 and A2 while unlabeled oligonucleotide A competed for
B1 and B2. However, unlabeled oligonucleotide A at 250 molar excess had
little effect on complex B4, suggesting that this protein bound
specifically to oligonucleotide B.
Since D2 contains regions of complex dyad symmetry, we tested for single-stranded D2 binding proteins in nuclear extracts by competition with unlabeled single-stranded oligonucleotides. Bands A1 and A2 observed with double-stranded 32P-labeled oligonucleotide A (32P-Oligo A) were partially competed by 250-fold excess of sense, but not by antisense, single-stranded oligonucleotide A (Fig. 5C). Other single-stranded oligonucleotides had no effect on these complexes. Bands B1 and B2 observed with double-stranded 32P-labeled oligonucleotide B (32P-Oligo B) were competed with unlabeled sense, but not by antisense, single-stranded oligonucleotide B or other single-stranded oligonucleotides (Fig. 5D). Band B3 was competed by single-stranded oligonucleotide A, B, and C, indicating it binds single-stranded DNA nonspecifically. The specific band B4 was not competed by any of the single-stranded D2 oligonucleotides. Taken together, the results suggest that related proteins with specificities for double- and single-stranded DNA are present in bands A1/A2 and B1/B2. In addition, band B4 binds duplex D2 exclusively.
Only one band was observed with 32P-labeled oligonucleotide
C, and it was competed with all unlabeled double-stranded
oligonucleotides used, indicating the presence of a nonspecific DNA
binding (data not shown). Although we were unable to detect specific
protein binding to 32P-labeled oligonucleotide C, DNase I
footprinting studies both in isolated nuclei and in vitro
indicated changes in DNase I digestion in the presence of ventral
prostate nuclear proteins in the 3 region of D2. One possibility is
that binding of proteins to the 5
and middle region of D2 induced
conformational changes that altered the sensitivity of the 3
-end of D2
to DNase I digestion.
The tissue
specificity of D2 complexes formed with ventral prostate nuclear
proteins and oligonucleotides A and B was tested using nuclear protein
extracts from male kidney and spleen, tissues that do not express the
20-kDa protein gene. Nuclear proteins from kidney and spleen bound D2
but with patterns distinct from that of ventral prostate nuclear
proteins. No major bands were detected with mobility identical to A1
and A2 (Fig. 6A) and B1 or B2 (Fig.
6B). Spleen contained a less intense band corresponding to
B4 (Fig. 6B), suggesting a protein involved in this complex is not restricted to ventral prostate or androgen target tissues.
Molecular Mass of Nuclear Proteins Bound to D2
UV
cross-linking was performed to determine the size of proteins bound to
32P-labeled oligonucleotides A and B. Bands A1 and A2 each
contained cross-linked protein-DNA complexes of approximately 140 and
70 kDa (Fig. 7A). The 70-kDa complex was a
minor component of A1 and a major component of A2. Band A3, a
nonspecific protein complex with 32P-labeled
oligonucleotide A (see Fig. 5) yielded a 70-kDa band but did not
contain the 140-kDa complex. B1 and B2 also contained complexes of 140 and 70 kDa, consistent with competition assays that suggested similar
proteins interacted with oligonucleotides A and B (Fig. 7B).
B3, a nonspecific complex in gel mobility shift assays (see Fig.
5B), also contained the 70-kDa protein. A protein of
approximately 55 kDa was observed with band B4 (Fig. 7B).
These results indicate that 32P-labeled oligonucleotides A
and B bind a 140-kDa protein or protein complex.
Androgen Dependence of D2 Binding of Nuclear Proteins
To
identify androgen-dependent proteins binding to
32P-labeled oligonucleotides A and B, mobility shift assays
were performed using ventral prostate nuclear proteins from 24- and
48-h postcastrated rats and from rats castrated and immediately given
testosterone for 48 h (Fig. 8). DNA-protein
complexes A1 and A2 with 32P-labeled oligonucleotide A
(Fig. 8A) and B1 and B2 with 32P-labeled
oligonucleotide B (Fig. 8B) decreased in intensity with castration in a time-dependent manner. Band B3 did not
change while band B4 decreased only slightly. The pattern of D2 binding proteins from castrated rats treated with testosterone was identical to
that of intact rats. The 55-kDa protein complex was also diminished by
androgen withdrawal but only slightly reduced 24 and 48 h after castration, perhaps due to a slower turnover.
Competition for Nuclear Proteins Binding to Full-length D2
Nuclear protein from ventral prostate of intact rats formed
complexes with 32P-labeled D2 that migrated at three
different positions (Fig. 9). Complexes 1 and 2 were
eliminated by an excess of unlabeled double-stranded oligonucleotide A
but not by oligonucleotide C. Complex 3 was competed only with an
excess of unlabeled oligonucleotide B. These results indicate that
ventral prostate nuclear proteins bind in the 5 and middle regions of
D2.
Intron 1 of the androgen-regulated 20-kDa protein gene contains a
130-bp sequence termed D2 that functions as a complex ARE in transient
cotransfection assays in CV1 cells (18). Our results indicate that AR
regulation of the 20-kDa protein gene involves D2 interactions with
other nuclear proteins and are consistent with earlier evidence that
the 20-kDa protein gene is a delayed primary response gene (19,
26-28). DNase I footprinting in isolated nuclei of ventral prostate
revealed androgen-dependent protected regions and
hypersensitive sites, indicative of androgen effects on chromatin
structure in the D2 region. This was supported by DNase I footprinting
in vitro, using nuclear protein extracts, that demonstrated
androgen-dependent protected regions and hypersensitive sites. Mobility shift assays identified androgen-dependent
nuclear protein complexes with the 5 and middle regions of D2
(oligonucleotides A and B). Androgen-dependent complexes
A1/A2 and B1/B2 interacted with double-stranded DNA of both regions but
also bound to sense strand sequences, especially in oligonucleotide B,
suggesting that binding might be influenced by the formation of
stem-loop structures within these regions of D2. Band B4 protein bound
exclusively to double-stranded DNA. Cross-linking analysis indicated
that the bands A1/A2 and B1/B2 contain a protein complex of
approximately 140 kDa, which was androgen-regulated, and B4, a complex
of 55 kDa, which was less diminished by androgen withdrawal. One of these proteins may interact with inverted repeat 2 (GATAAA; Fig. 1)
present in the 5
and middle region of D2 since this sequence contained
androgen-dependent protected and hypersensitive sites. Inverted repeats may be associated with hormone response elements or
other transcription control elements (18, 32, 33). In D2, inverted
repeat 2 encompasses a candidate ARE (GTTACAaagTATGAC), portions of
which are either protected or contain hypersensitive sites.
Proteins interacting with D2 may promote selective binding or transcriptional activity of AR. De Vos et al. (34) reported that nuclear extracts from a variety of tissues enhance binding of AR to intron fragments of the C3 subunit gene. The high mobility group chromatin protein HMG-1 is a sequence-independent DNA-binding protein that binds preferentially in regions of secondary DNA structure (35). Recognition of DNA structure is mediated by a conserved HMG box motif (36). The HMG box motif is also present in transcription regulatory factors that bind specific DNA sequences, notably testis determining factor (37) and lymphoid enhancer factor 1 (38). Prendergast et al. (39) reported that purified HMG-1 enhances the binding of PR to its response element by 10-fold. Enhancement of PR DNA binding requires the HMG-1 DNA binding domain, suggesting it results from DNA bending, a known property of HMG-1. The configuration of DNA in a response element (40) may alter receptor tertiary structure (41, 42) and thereby effecting transactivation (43, 44). Interactions with nuclear receptor ligand-dependent coactivators (45) such as the AR-associated protein (ARA-70) (46) may be influenced by response element structure.
A number of reports indicate that regulation of gene expression involves a complex array of single- and double-stranded DNA binding proteins. The myogenic determination factor, Myo D1, binds to single- and double-stranded DNA containing regulatory elements from muscle-specific genes (47), and a regulatory element in the mouse adipsin gene binds multiple regulatory proteins, two of which preferentially bind to single-stranded DNA (48). Supakar et al. characterized a novel regulatory element associated with age-dependent expression of the AR gene in rat liver (49). Grossman and Tindall (50) identified nuclear proteins that bind single-stranded DNA in a supressor region of the AR gene promoter. Steroid induction of ovalbumin gene transcription in chicken oviduct is mediated by single- and double-stranded DNA binding protein interactions within a steroid-dependent regulatory element. At least two of these nuclear proteins are induced by estrogen (51, 52).
Functional synergism between multiple ARE-like sequences and binding
sites for other transcription factors has been observed in the
androgen-regulated C3 gene (22, 23). In the complex enhancer element of
the Slp gene, binding of several non-receptor proteins contributes to
the characteristic androgen response (10-15). Footprinting in isolated
nuclei and in vitro indicated that these factors are
influenced by androgens (12). Androgen dependence of the D2-binding
proteins reported in the present study indicates that androgens may be
involved both directly and indirectly in the regulation of 20-kDa
protein gene transcription by way of this complex response element,
directly through interactions of the AR with D2 and indirectly by
controlling the expression or modification of nonreceptor D2 binding
proteins. Androgen-dependent DNA binding proteins have been
identified in intron 9 of the -glucuronidase gene in mouse kidney
(32) and in the promoter region of the mouse RP2 gene (20). A factor
that recognizes the 5
-flanking region of the mouse RP2 gene is present
in kidney nuclear extracts from both control and androgen-treated
Mus domesticus as well as from control Mus
caroli. However, in the latter species, a distinct
androgen-induced DNA binding protein replaced the protein bound in the
absence of androgen, showing that androgen can modulate the level and
activity of a DNA-binding protein in a species- and tissue-specific
manner. Thus, tissue-specific proteins may have a role in determining
both the magnitude and specificity of gene induction. Our results
demonstrate that kidney and spleen, organs in which the 20-kDa protein
gene is not expressed, did not contain the same nuclear D2 binding
proteins as ventral prostate.
One hypothesis for steroid hormone modulation of gene expression suggests that receptor binding to response element DNA leads to disruption of phased nucleosomes, allowing access of other transcription factors to their binding elements (53). Another model postulates that steroid receptors exert effects on preexisting protein-DNA structure through modification of transacting factors or addition of accessory transcription factors (54). GR-induced alteration of chromatin structure in certain promoters and enhancers of hormone-responsive genes is indicated by the appearance of hormone-dependent DNase I hypersensitive sites (55-58). The general view is that these hypersensitive sites represent nucleosome-free regions of DNA (59, 60); however, the mechanism of nucleosome disruption is not fully understood (61).
Data in this report indicate that AR regulation of 20-kDa protein gene transcription by way of its intron 1 response element D2 is mediated in association with androgen dependent single- and double-stranded DNA binding proteins. These D2 binding proteins could be rapidly turning-over gene products regulated by androgens transcriptionally or post-transcriptionally. Although functions of these proteins have yet to be determined, they remain candidate modulators of the AR-specific response element.
We thank De-Ying Zhang for technical assistance and Ron Knight and Billy Bolton for administrative and secretarial help. We are grateful to Elizabeth M. Wilson for critical reading of the manuscript and helpful suggestions.